Dipeptidyl-peptidase-4 inhibitors have anti-inflammatory effects in patients with type 2 diabetes

ConclusionThis meta-analysis demonstrated that DPP-4 inhibitors can significantly attenuate low-grade inflammatory state in patients with T2DM. In addition to improving glycemic control, DDP-4 inhibitors might offer extra therapeutic value by controlling inflammation.Graphical Abstract
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research